The browser doesnot support javascript
Print Plan Forms | Help

Medication Safety Alerts

0.9% Sodium Chloride Injection 250 mL VisIVT flex container Voluntary Recall


On March 5, 2015, the United States Food and Drug Administration (FDA) issued a notice regarding a voluntary recall of 0.9% Sodium Chloride Injection 250 mL VisIV™ flex container manufactured by Hospira, Inc. This recall was issued because a hair was floating in the solution.

This may represent a potential health hazard or safety risk to plan members who may be using product affected by this recall.

This recall affects lot number 45-110-C6 exp. 03/16. The lot number may be followed by 01 to 99. To see if you have affected product, please check the lot number which is located on the bag on the manufacturer’s label. If your product is not from lot number 45-110-C6, it is not affected by this recall. If your product is from lot number 45-110-C6, please return it to the pharmacy that filled your prescription.

You should not continue to use product that is affected by this recall. Please call your doctor right away for advice if you may be using affected product. Your doctor is familiar with your medical history and can suggest the best treatment option for you. If you need a prescription for a different medicine, please call your doctor.

CVS/caremark Response: Please note: This product is not carried by the CVS Caremark Mail Service Pharmacies.

If you are currently using 0.9% Sodium Chloride Injection 250 mL VisIV™ flex container and have questions regarding this recall, please call your doctor or call Hospira Medical Communications toll-free at 1‑800‑615‑0187 or visit You may also call the FDA consumer inquiry line toll-free at 1‑888‑INFO-FDA (1‑888‑463‑6332) or visit their Web site at

The CVS/caremark™ app lets you manage your prescription benefits on the go. Download it now:

CVS Health LogoCVS Pharmacy LogoCVS Minute Clinic LogoCVS Specialty LogoSilverscript LogoAccordant Logo

Copyright © 2018 CVS/caremark. All rights reserved| Terms and Conditions | Privacy Policy | Accessibility | Member Rights & Responsibilities